Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Medical Oncology Physician in Syracuse, NY
NPI: 1437316304Primary Practice Location
UNIVERSITY HOSPITAL S U N Y HEALTH SCIENCE CENTER
4900 Broad Rd, Syracuse, NY
Primary Employer
Department of Medicine Medical Serv Grp at SUNY Hlth Sci Ctr Syr In
upstatemedicine.com
HQ Phone
Get M.D. Sam's Phone Numberphone_androidMobile
Get M.D. Sam's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Masaryk University Faculty of Medicine
Medical School
Until 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 329 | 753 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 150 | 206 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 74 | 74 |
| 4 | 99223Initial hospital inpatient care, typically 70 minutes per day | 22 | 24 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 19 | 108 |
Hemophagocytic lymphohistiocytosis: an uncommon presentation of enteropathy-associated T-cell lymphoma.
Authors: Dona Varghese, Stephen Knohl, Sujith Cherian
Publication Date: 2013-03-27
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: Canadian Cancer Trials Group
Intervention / Treatment: DRUG: Sunitinib Malate, PROCEDURE: Biospecimen Collection, DRUG: Crizotinib, PROCEDURE: Computed Tomography, DRUG: Cabozantinib S-malate, PROCEDURE: Bone Scan, DRUG: Savolitinib
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Laboratory Biomarker Analysis, DRUG: Cyclophosphamide, DRUG: Paclitaxel, DRUG: Doxorubicin Hydrochloride
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: placebo, DRUG: tamoxifen citrate, DRUG: everolimus, DRUG: anastrozole, DRUG: exemestane, DRUG: letrozole, DRUG: goserelin acetate, DRUG: leuprolide acetate
